Frank J. Williams - 01 Dec 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Director
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol: EVH
Transactions as of: 01 Dec 2022
Net transactions value: -$2,690,220
Form type: 4
Filing time: 05 Dec 2022, 15:58:52 UTC
Previous filing: 03 Nov 2022
Next filing: 05 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Options Exercise	$422,400	+110,000	+18%	$3.84^*	736,479	01 Dec 2022	Direct	F1, F2
transaction	EVH	Class A Common Stock	Sale	$3,086,439	-109,100	-15%	$28.29	627,379	01 Dec 2022	Direct	F1, F2, F3
transaction	EVH	Class A Common Stock	Sale	$26,181	-900	-0.14%	$29.09	626,479	01 Dec 2022	Direct	F1, F2, F4
holding	EVH	Class A Common Stock						66,064	01 Dec 2022	See footnote	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVH	Class A Common Stock Option (right to buy)	Options Exercise	$0	-110,000	-32%	$0.000000	229,060	01 Dec 2022	Class A Common Stock	110,000	$3.84	Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022.
F2	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.997 to $28.890, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.070 to $29.180, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5	Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
F6	The Class A Common Stock Options exercised vested on December 1, 2016.